Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity - USD ($) $ in Thousands	Total	Registered Direct Offering	Public offering	Game Your Game	Visualix	CXApp	Series 4 Convertible Preferred Stock	Series 5 Convertible Preferred Stock	Common Stock	Common Stock Registered Direct Offering	Common Stock Public offering	Common Stock Game Your Game	Common Stock Visualix	Common Stock CXApp	Additional Paid-In Capital	Additional Paid-In Capital Registered Direct Offering	Additional Paid-In Capital Public offering	Additional Paid-In Capital Game Your Game	Additional Paid-In Capital Visualix	Additional Paid-In Capital CXApp	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-Controlling Interest	Non-Controlling Interest Game Your Game	Series 7 Preferred Stock
Convertible preferred stock, ending balance at Dec. 31, 2020																										$ 0
Balance, beginning (in shares) at Dec. 31, 2019							1	126	4,234,923												(1)
Balance, beginning at Dec. 31, 2019	$ 6,050						$ 0	$ 0	$ 4						$ 158,382						$ (695)	$ 96	$ (151,763)	$ 26
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued (in shares)										5,000,000	33,416,830
Common shares issued		$ 9,205	$ 46,143							$ 5	$ 33					$ 9,200	$ 46,110
Common shares issued for extinguishment of debt (in shares)									6,863,223
Common shares issued for extinguishment of debt	$ 9,936								$ 7						9,929
Common shares issued for cashless stock options exercised	0
Common shares issued for net proceeds from warrants exercised (in shares)	3,000,000
Common shares issued for net proceeds from warrants exercised	$ 3
Stock options and restricted stock awards granted to employees and consultants for services	1,193														1,193
Issuance of shares from acquisition (in shares)									480,000
Issuance of shares from acquisition	600								$ 1						599
Common shares issued for extinguishment of liability (in shares)									183,486
Common shares issued for extinguishment of liability	200														200
Cumulative translation adjustment	564																					564
Net Loss	(29,214)																						(29,229)	15
Balance, ending (in shares) at Dec. 31, 2020							1	126	53,178,462												(1)
Balance, ending at Dec. 31, 2020	44,680						$ 0	$ 0	$ 53						225,613						$ (695)	660	(180,992)	41
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Mezzanine equity, convertible preferred stock, shares outstanding (in shares)																										0
Series 7 Preferred Stock issued for cash (in shares)																										58,750
Series 7 Preferred Stock issued for cash																										$ 46,034
Series 7 Preferred Stock converted to common stock (in shares)																										(9,500)
Series 7 Preferred Stock converted to common stock																										$ (9,500)
Accrete Discount - Preferred Shares																										8,161
Convertible preferred stock, ending balance at Dec. 31, 2021																										$ 44,695
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares issued (in shares)										15,800,000
Common shares issued	4,551	$ 74,073								$ 15					4,551	$ 74,058
Common shares issued for extinguishment of debt (in shares)									1,771,113
Common shares issued for extinguishment of debt	$ 2,500								$ 2						2,498
Common shares issued for cashless stock options exercised	20,694								5,391
Common shares issued for net proceeds from warrants exercised (in shares)									31,505,088
Common shares issued for net proceeds from warrants exercised	$ 3,779								$ 32						3,747
Stock options and restricted stock awards granted to employees and consultants for services	10,879														10,879
Issuance of shares from acquisition (in shares)												1,179,077	369,563	8,849,538
Issuance of shares from acquisition				$ 3,875	$ 429	$ 10,000						$ 1		$ 9				$ 1,402	$ 429	$ 9,991					$ 2,472
Common shares issued for restricted stock (in shares)									4,672,988
Common shares issued for restricted stock grants	0								$ 5						(5)
Taxes paid on stock based compensation	(1,855)														(1,855)
Series 7 Preferred Stock converted to common stock (in shares)									7,600,000
Series 7 Preferred Stock converted to common stock	9,500								$ 8						9,492
Accrete Discount - Preferred Shares	(8,161)														(8,161)
Restricted stock grants forfeited (in shares)									(490,296)
Restricted stock grants forfeited	(1)								$ (1)
Cumulative translation adjustment	(628)																					(616)	(162)	150
Net Loss	(70,130)																						(69,155)	(975)
Balance, ending (in shares) at Dec. 31, 2021							1	126	124,440,924												(1)
Balance, ending at Dec. 31, 2021	$ 83,491						$ 0	$ 0	$ 124						$ 332,639						$ (695)	$ 44	$ (250,309)	$ 1,688
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Mezzanine equity, convertible preferred stock, shares outstanding (in shares)																										49,250